Glucagon for Injection Kit
Glucagon for Injection is bioequivalent and therapeutically equivalent to the Glucagon Emergency Kit for Low Blood Sugar. It is indicated for the treatment of severe hypoglycemia and for use as a diagnostic aid (see Glucagon for Injection Full Prescribing Information). Glucagon for Injection is packaged in an emergency kit containing Glucagon for Injection, 1mg/vial and Diluent for Glucagon, 1mL Syringe.
Epinephrine Injection, USP
Epinephrine Injection, USP is the generic equivalent to Adrenalin® indicated for emergency treatment of allergic reactions (Type I), including anaphylaxis, which may result from insect stings or bites, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. Epinephrine Injection, USP is also indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock (see Epinephrine Injection, USP Full Prescribing Information). Epinephrine Injection, USP is available in 30 mg/30 mL multiple dose vials.
Enoxaparin Sodium Injection
Enoxaparin Sodium Injection is the generic equivalent to Lovenox® indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism and the inpatient/outpatient treatment of acute deep vein thrombosis (see Enoxaparin Sodium Injection Full Prescribing Information). Enoxaparin is available in multiple dose vials and prefilled syringes with UltraSafe® Needle Guard making it fully compliant with the Needlestick Safety and Prevention Act. Amphastar's Enoxaparin is available in eight dosage forms.
Cortrosyn® (cosyntropin for Injection) is a diagnostic agent used in the screening of patients presumed to have adrenocortocal insufficiency. With Cortrosyn's rapid effect on the adrenal cortex, it may be utilized to perform a 30-minute test of adrenal function (plasma cortisol response) as an office or outpatient procedure requiring only two venipunctures (see Cortrosyn® Professional Prescribing Information).
Amphadase® (hyaluronidase injection, USP)
Amphadase® (hyaluronidase injection, USP) is an enzyme that breaks down hyaluronic acid in connective tissue, increasing tissue permeability. Hyaluronidase is typically used as an adjunctive agent to facilitate the dispersion and absorption of other drugs. It is used in local anesthesia to increase the area affected and speed the onset of action, especially in nerve-block anesthesia and anesthesia prior to ophthalmic surgery (see Amphadase® Professional Prescribing Information).
Medroxyprogesterone Acetate Injectable Suspension, USP
Medroxyprogesterone Acetate Injectable Suspension, USP is the generic equivalent to Depo-Provera® indicated for the prevention of pregnancy. The loss of bone mineral density (BMD) in women of all ages and the impact on peak bone mass in adolescents should be considered, along with the decrease in BMD that occurs during pregnancy and/or lactation, in the risk/benefit assessment for women who use Medroxyprogesterone acetate long-term. Medroxyprogesterone Acetate Injectable Suspension, USP is available in single-dose vials and prefilled syringes.
Isoproterenol Hydrochloride Injection, USP
Isoproterenol Hydrochloride Injection, USP is indicated for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy, for serious episodes of heart block and Adams-Stokes attacks (except when caused by ventricular tachycardia or fibrillation,) for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, is available, for bronchospasm occurring during anesthesia, as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure, and cardiogenic shock.
Neostigmine Methylsulfate Injection, USP
Neostigmine Methylsulfate Injection, USP is a cholinesterase inhibitor indicated for the reversal of the effects of nondepolarizing neuromuscular blocking agents after surgery.
Emergency Syringes in Luer-Jet™
Amphastar’s subsidiary, International Medication System, Ltd. (IMS), utilizes the proprietary prefilled disposable emergency syringes for
crash cart use. Emergency syringes are provided in the Luer-Jet™;
a completely needleless, Luer Lock syringe. Luer-Jet™ complies with OSHA's Needlestick Safety and Prevention Act, and is compatible with most Luer Activated Systems (including ICU Medical Clave® Valve).
• Atropine Sulfate Injection, USP
• Calcium Chloride Injection, USP
• Dextrose Injection, USP
• Epinephrine Injection, USP
• Lidocaine HCI Injection, USP
• Sodium Bicarbonate Injection, USP
• Lidocaine HCl Jelly, USP, 2% (Preservative Free), URO-Jet® is
a preservative-free topical local anesthetic agent and is provided
in the uniquely designed Uro-Jet prefilled syringe, which is specially
designed to reduce discomfort during the product application.
• Lidocaine HCl, 4% Topical Solution, USP-Laryng-O-Jet® is
indicated for the topical anesthesia of the respiratory tract. It is
provided in the Laryng-O-Jet prefilled syringe, which is designed to
reduce discomfort during product application.
Naloxone HCl Injection, USP, 2mg/2mL:
Naloxone HCl Injection is indicated for the complete or partial reversal of narcotic depression and diagnosis of suspected acute opioid overdose.
Provided in 2 types of prefilled syringes for convenient, safe, and quick Intravenous, Intramuscular, and Subcutaneous administration:
• Needleless Luer Jet Prefilled Syringe: completely needleless
syringe, provided in Luer Lock syringe, complies with OSHA's
Needlestick Safety and Prevention Act. Compatible with most
Luer Activated Systems (includes ICU Medical Clave® Valve)
• Min-I-Jet Prefilled syringe with 21 Gauge and 1 ½” fixed Needle
Phytonadione Injection (Vitamin K1) for newborns has been on the market for many years. Recently, however, with the trend moving towards safe needle technology, IMS has combined its product’s configuration with the Saf-T-Jet™ prefilled syringe, which complies with the Needlestick and Safety Prevention Act.
Procainamide Hydrochloride Injection, USP
Procainamide Hydrochloride Injection, USP is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. Because of the proarrhythmic effects of procainamide, its use with lesser arrhythmias is generally not recommended. Treatment of patients with asymptomatic ventricular premature contractions should be avoided.